Drugs Used in HPN Flashcards

1
Q

Toxicities of Thiazides

A
HYPER GLUC
Glycemia
Lipidemia
Uricemia
Calcemia

hypokalemic metabolic alkalosis

hypercalcemia
hypercalciuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Toxicities of Loop Diuretics

A

OH DANG

Ototoxicity
Hypokalemia
Dehydration
Allergy to Sulfa
Nephritis
Gout

hypocalcemia
hypercalciuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drugs that can cause GINGIVAL HYPERPLASIA

A

Nifedipine
Cyclosporine
Phenytoin
Verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drugs used to CONTROL BP in PHEOCHROMOCYTOMA

A

Phenoxybenzamine
Phentolamine
Labetalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications that may cause DRUG INDUCED LUPUS

A

HIPP

Hydralazine
Isoniazid
Procainamide
Penicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Accelerated form of severe HPN associated w/ rising BP and rapidly progressing end organ damage

A

MALIGNANT HYPERTENSION

Management:

  • Nitroprusside, Fenoldopam or Diaxozide) PLUS Diuretics (Furosemide) and Beta Blockers
  • lower BO to 140-160/90-110
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diuretics

INC UO – DEC BV — DEC CO — DEC BP

A
THIAZIDE
Chlorothiazide
Hydrochlorothiazide
Indapamide
Chlorthalidone
Metolazone
LOOP 
Furosemide
Torsemide
Bumetanide
Ethacrynic Acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of Sympatholytics in treating HPN

A

(-) SYMPA – DEC HR

DEC VR. DEC HR, DEC contractile force
DEC CO, DEC TPR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CNS Sympa Outflow Blockers

A

alpha 2 agonist

Clonidine
Methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes rebound HPN upon withdrawal

A

Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes hemolytic anemia and (+) Coombs test

A

Methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alpha 1 Blockers

A

Prazosin
Terazosin
Doxazosin
Alfuzosin

Tamsulosin
Silodosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes orthostatic hypotension

A

Alpha 1 Blockers

Prazosin
Terazosin
Doxazosin
Alfuzosin

Tamsulosin
Silodosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of Beta Blockers in treating HPN

A

DEC HR, DEC contraction –> DEC CO –> DEC BP

block renin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SELECTIVE Beta Blockers

A

BBEAAMC

Betaxolol
Bisoprolol
Esmolol
Atenolol
Acebutol
Misoprolol
Celiprolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NON SELECTIVE Beta Blockers

A
Propanolol
Penbutolol
Carteolol
Carvedilol
Labetalol
Timolol
Nadolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ganglion Blockers

NOT longer used d.t. side effects

A

Hexamethonium
Trimethaphan
Mecamylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nerve Terminal Blockers

NOT used anymore d.t. PSYCHIATRIC side effects

A

Reserpine

Guanethidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Irreversibly blocks VMAT

A

Reserpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(-) Vesicular Release of NE

A

Guanethidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vasodilators

directly RELAXES arterioles – DEC TPR

A

Hydralazine
Sodium Nitroprusside
Diazoxide
Minoxidil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Adverse effects of Hydralazine

A

SLE

reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Adverse effects of Sodium Nitroprusside

A

hypotension

cyanide toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

MOA of CCB in treating HPN

A

smooth muscle relaxation –> vasodilation –> DEC TPR –> DEC BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
DIHYDROPYRIDINE CCB
1st Gen Nifedipine ``` 2nd Gen Amlodipine Felodipine Isradipine Nicardipine Nisoldipine Nimodipine ```
26
NON - DIHYDROPYRIDINE CCB
Verapamil | Diltiazem
27
Adverse effects of DIHYDROPYRIDINE CCB
pretibial edema | constipation
28
Adverse effect of Verapamil
gingival hyperplasia
29
MOA of Nitroprusside in treating HPN
INC NO --> INC cGMP --> smooth muscle relaxation
30
MOA of Fenoldopam in treating HPN
DOPAMINE AGONIST arteriolar vasodilation of afferent and efferent arterioles
31
MOA of ACE (-) in treating HPN
DEC angiotensin --> DEC vasoconstriction --> PR DEC angiotensin II --> DEC aldosterone --> NaH20 retention --> DEC BV --> DEC CO DEC aldosterone --> K retention (hyperkalemia)
32
ACE Inhibitors
-PRIL Captopril Enalapril Benazepril Fosinopril
33
MOA of Angiotensin Receptor Blockers in treating HPN
blocks the binding of ang II to ang II receptors --> DEC TPR (afterload) and DEC venous tone (preload) DEC aldosterone --> K retention (hyperkalemia)
34
Adverse effects of ACE Inhibitors
cough | angioedema
35
Adverse effects of Angiotensin Receptor Blockers
hypotension hyperkalemia teratogenic
36
Treatment for Uncomplicated HPN 140/90 - therapeutic threshold 130/80 - GOAL
MONOTHERAPY/ COMBINED ACE (-) or ARBs CCBs Thiazide
37
Treatment for HPN w/ CAD, ACS, high sympathetic drive and pregnant women
Beta Blockers CHF *Bisoprolol, Carvedilol, Metoprolol Succinate, Nebivolol
38
Treatment for BP >150/100 elderly - BP 160/100
ARB or ACE (-) PLUS CCB or Diuretics
39
Treatment for HPN + DM ≥ 140/90 - therapeutic threshold 130/80 - GOAL XXX - 120/70
LOW DOSE COMBINATION of RAAS BLOCKERS (ACE (-) OR ARBs) AND CCB OR Thiazide or Thiazide like diuretics
40
Treatment for CKD PREDIALYSIS ≥ 140/90 - therapeutic threshold <140/90 - TARGET for LOW RISK <130/80 - TARGET for HIGH RISK
REDUCE CV EVENTS IN CKD Px ACE (-) ARBs Thiazide-like diuretics Dihydropyridine Calcium Blockers
41
Treatment for CKD + albuminuria/proteinuria
ACE (-) or ARBs (at maximally tolerated dose) - 1ST LINE *UACR ≥ 30 CCB (NON-Dihydropyridine) Verapamil Diltiazem
42
ACE (-) or ARBs used for the treatment of CKD albuminuria/proteinuria should NOT be discontinued UNLESS
serum crea rise >30% over baseline during the 1st 2 mos hyperkalemia (>5.6 mmol/L)
43
Treatment for CKD + resistant HPN
Mineralocorticoid Receptor Antagonist * Eplerenone * Spironolactone
44
Treatment for CKD BP ≥ 160/100
2 DRUGS or SINGLE PILL COMBINATIONS address volume depletion type of HPN *CCB and Diuretics for renin dependent type *ACE, ARB, Beta Blockers
45
Acute Ischemic Stroke (AIS) eligible for IV thrombolysis but NOT for mechanical thrombectomy BP >185/110 - therapeutic threshold BP <185/110 - maintained prior to treatment and during infusion BP <180/105 next 24 h after treatment
referral to neurologist or stroke generalist NICARDIPINE 1-5 mg/h titrated up by 2.5 mg/h q 5-15 mins w/ maximum of 15 mg/h LABETALOL 10 mg IV now over 1-2 min followed by continuous IV infusion of 2-8 mg/min
46
Acute Ischemic Stroke (AIS) NOT eligible for IV thrombolysis or mechanical thrombectomy 110-130 mmHg - MAP TARGET >220 SBP - therapeutic threshold > 120 DBP
NICARDIPINE reduce the BP by 15% during the 1st 24 h after the onset of stroke
47
Acute Hypertensive Parenchymal Intracerebral Hemorrhage (ICH) SBP ≥ 180 - Therapeutic Threshold SBP <180 - GOAL
NICARDPINE - DOC Labetalol careful lowering to 140-160
48
(+) history of stroke 140/90 - Therapeutic Threshold ≤ 130/80 - GOAL
RAS Blockers, CCBs, Thiazides
49
Thiazide Diuretics (-) Na/Cl transporters for HPN, HF, hypercalciuria, renal calcium stones, nephrogenic diabetes insipidus
"MICH" Metolazone Indapamide Chlorthalidone Hydrochlorothiazide
50
Appears in cord blood and crosses placenta and may cause hypokalemia, hyponatremia, hypoglycemia, jaundice and thrombocytopenia
Metolazone
51
Loop Diuretics (-) Na/K/2Cl transporter powerful diuresis, increased calcium excretion HF, pulmonary edema hypercalcemia, acute renal failure, anion overdose
Furosemide Bumetanide Torsemide Ethacrynic Acid - can be used in px with sulfur allergy
52
Drugs used to control BP in pheochromocytoma
Phenoxybenzamine Phentolamine Labetalol
53
Common SE of vasodilators
hypotension reflex tachycardia edema headache
54
Most effective vasodilator Bort arteriolar and venodilator SE: cyanide toxicity
Nitroprusside increase NO -- increase cGMP -- smooth muscle relaxation
55
D1 receptor agonist Arteriolar vasodilation of afferent and efferent arterioles INCREASED renal blood flow
Fenoldopam
56
MOA of Vasodilators
alters intracellular calcium metabolism (Hydralazine) opens K channels in vascular smooth muscle = hyperpolarization - smooth muscle relaxation = vasodilation (Minoxidil, Diazoxide) Calcium channel blockade increase NO -- increase cGMP -- smooth muscle relaxation D1 receptor agonist - Fenoldopam
57
Alters intracellular calcium metabolism vasodilates ARTERIOLES -- decreased afterload for preeclampsia, HPN heart failure - + ISDN SE: psychiatric depression, suicidal ideation DRUG INDUCED LUPUS MI
Hydralazine
58
Opens K channels in vascular smooth muscle = hyperpolarization - smooth muscle relaxation = vasodilation for alopecia, HPN SE: hirsutism DRUG INDUCED LUPUS
Minoxidil *stimulates hair follicles (telogen phase) to differentiate into growth follicles (anagen phase) Diazoxide
59
Angiotensin Receptor Blockers
-SARTANS ``` Losartan Candesartan Valsartan Telmisartan Irbesartan Eprosartan Azilsartan Olmesartan ```
60
Drug Induced Lupus
HIPP Hydralazine Isoniazid Procainamide Penicillamine
61
Why are patients with diabetic nephropathy treated with ACE (-)
ACE (-) decrease albumin excretion and slow progression from micro - to - macroalbuminuria (renoprotective effect)